Um. Wewer et al., TETRANECTIN IS A NOVEL MARKER FOR MYOGENESIS DURING EMBRYONIC-DEVELOPMENT, MUSCLE REGENERATION, AND MUSCLE-CELL DIFFERENTIATION IN-VITRO, Developmental biology (Print), 200(2), 1998, pp. 247-259
Tetranectin, a plasminogen-binding protein with a C-type lectin domain
, is found in both serum and the extracellular matrix. In the present
study we report that tetranectin is closely associated with myogenesis
during embryonic development, skeletal muscle regeneration, and muscl
e cell differentiation in vitro. We find that tetranectin expression c
oincides with muscle differentiation and maturation in the second half
of gestation and further that tetranectin is enriched at the myotendi
nous and myofascial junctions. The tetranectin immunostaining declines
after birth and no immunostaining is observed in normal adult muscle.
However, during skeletal muscle regeneration induced by the intramusc
ular injection of the myotoxic anesthetic Marcaine, myoblasts, myotube
s, and the stumps of damaged myofibers exhibit intense tetranectin imm
unostaining. Tetranectin is also present in regenerating muscle cells
in dystrophic mdx mice. Murine C2C12 myogenic cells and pluripotent em
bryonic stem cells can undergo muscle cell differentiation in vitro. T
etranectin is not expressed in the undifferentiated myogenic cells, bu
t during the progression of muscle differentiation, tetranectin mRNA i
s induced, and both cytoplasmic and cell surface tetranectin immunosta
ining become apparent. Finally, we demonstrate that while tetranectin
mRNA is translated to a similar degree in developing limbs and lung, t
he protein does not seem to be tissue associated in the lung as it is
in the limbs. This indicates that in some tissues, such as the limbs,
tetranectin may function locally, whereas in other tissues, such as th
e lung, tetranectin production may be destined for body fluids. In sum
mary, these results suggest that tetranectin is a matricellular protei
n and plays a role in myogenesis. (C) 1998 Academic Press.